ChemDiv and Institut Pasteur Korea Announce Partnership
ChemDiv, Inc. (ChemDiv), and Institut Pasteur Korea (IPK) announced that they have entered into collaboration for the discovery and development of new drugs against tuberculosis disease (TB).
Under the terms of this collaboration, ChemDiv will provide IPK with its research small molecules series for TB. ChemDiv will contribute other services of its Discovery outSource platform. IPK will contribute its unique high content and throughput visual TB assays, as well as animal models for TB drug discovery.
Other news from the department science
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.